CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,216,825 | -15.9% | 7,648,268 | 0.0% | 18.48% | +11.5% |
| Q2 2023 | $82,295,364 | +5.2% | 7,648,268 | 0.0% | 16.57% | -18.5% |
| Q1 2023 | $78,241,782 | -3.0% | 7,648,268 | 0.0% | 20.33% | -2.9% |
| Q4 2022 | $80,689,227 | -17.7% | 7,648,268 | 0.0% | 20.93% | -9.9% |
| Q3 2022 | $98,051,000 | 0.0% | 7,648,268 | 0.0% | 23.22% | -14.7% |
| Q2 2022 | $98,051,000 | +22.4% | 7,648,268 | 0.0% | 27.24% | +26.7% |
| Q1 2022 | $80,077,000 | -32.1% | 7,648,268 | 0.0% | 21.49% | -0.1% |
| Q4 2021 | $118,013,000 | -31.6% | 7,648,268 | 0.0% | 21.52% | -19.6% |
| Q3 2021 | $172,621,000 | -15.3% | 7,648,268 | -3.4% | 26.78% | -20.0% |
| Q2 2021 | $203,783,000 | -38.2% | 7,913,887 | 0.0% | 33.48% | -19.2% |
| Q1 2021 | $329,772,000 | – | 7,913,887 | – | 41.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |